The Enterprise Value as of November 2024 (TTM) for Adial Pharmaceuticals, Inc. (ADIL) is 3.18M

According to Adial Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.18M. This represents a change of 309.68% compared to the average of 776.64K of the last 4 quarters.

Adial Pharmaceuticals, Inc. (ADIL) Historical Enterprise Value (quarterly & annually)

How has ADIL Enterprise Value performed in the past?

The mean historical Enterprise Value of Adial Pharmaceuticals, Inc. over the last ten years is 17.38M. The current 3.18M Enterprise Value has changed 1.73% with respect to the historical average. Over the past ten years (40 quarters), ADIL's Enterprise Value was at its highest in in the September 2021 quarter at 78.24M. The Enterprise Value was at its lowest in in the March 2024 quarter at -1391797.01.

Adial Pharmaceuticals, Inc. (ADIL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Adial Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Adial Pharmaceuticals, Inc. (ADIL) Average Enterprise Value

How has ADIL Enterprise Value performed in the past?

The current Enterprise Value of Adial Pharmaceuticals, Inc. (ADIL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Adial Pharmaceuticals, Inc. (ADIL) Enterprise Value vs. Peers

How is ADIL’s Enterprise Value compared to its peers?

Adial Pharmaceuticals, Inc.’s Enterprise Value is less than TransCode Therapeutics, Inc. (5.66M), less than Aditxt, Inc. (12.17M), less than Reviva Pharmaceuticals Holdings, Inc. (28.86M), greater than Avenue Therapeutics, Inc. (-1724348.00), greater than Applied Molecular Transport Inc. (-5743713.00), less than Catalyst Biosciences, Inc. (19.42M), less than Aileron Therapeutics, Inc. (63.85M), greater than Bio-Path Holdings, Inc. (-369925.00), less than Benitec Biopharma Inc. (162.42M), greater than Hoth Therapeutics, Inc. (-3468661.00), greater than Revelation Biosciences, Inc. (-8887351.00), greater than NeuroBo Pharmaceuticals, Inc. (-4849640.00), less than Virax Biolabs Group Limited (5.45M), less than RenovoRx, Inc. (12.72M), greater than Axcella Health Inc. (-7493000.00), less than Better Therapeutics, Inc. (7.71M), greater than Pasithea Therapeutics Corp. (-4396812.00), less than Onconova Therapeutics, Inc. (4.51M), greater than Diffusion Pharmaceuticals Inc. (-1447403.00), greater than Aeterna Zentaris Inc. (-11767918.00), less than Tonix Pharmaceuticals Holding Corp. (24.41M),

Build a custom stock screener for Adial Pharmaceuticals, Inc. (ADIL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adial Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Adial Pharmaceuticals, Inc. (ADIL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Adial Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.